Device recall: Burlington Medical, Thyroid Shield.
Class II FDA enforcement event 98415. Recall start date: . Status in the FDA record: Ongoing.
Reason for recall, in the words of FDA
Potential for attenuation degradation over time, decreasing the lifespan.
Class II, in the words of FDA
a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Burlington Medical, LLC started this device recall on 11 Feb 2026. The firm address in the FDA record is in Newport News, VA. FDA put the recall in Class II. FDA event 98415 has 13 product records. The first FDA enforcement report date is 8 Apr 2026. The record gives the status Ongoing.
It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.
FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .
Distribution
In the words of FDA.
Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand,…
Recalling firm
Burlington Medical, LLC, Newport News, VA.
Recalling firm: The firm that the FDA record names for a recall.
FDA records how the recall started: Voluntary: Firm initiated.
Products
13 product records in the event.
| Recall number | Product | Quantity | Class | Status | Report date |
|---|---|---|---|---|---|
| Z-1753-2026 | Burlington Medical, Thyroid Shield. | 41,962 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1754-2026 | Burlington Medical, Vest | 15,438 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1755-2026 | Burlington Medical, Kilt | 15,216 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1756-2026 | Burlington Medical, Frontal Aprons | 14323 | Class II | Ongoing | 8 Apr 2026 |
| Z-1757-2026 | Burlington Medical, Wrap Aprons. | 5,198 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1758-2026 | Burlington Medical, BAT (Breast, Axilla and Thyroid) Coverage. | 1,489 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1759-2026 | Burlington Medical, Protective Sleeves. | 1,129 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1760-2026 | Burlington Medical, Caps. | 961 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1761-2026 | Burlington Medical, Leg Wraps. | 103 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1762-2026 | Burlington Medical, Half Aprons. | 402 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1763-2026 | Burlington Medical, Demi Half Aprons. | 29 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1764-2026 | Burlington Medical, Blockers. | 51 units | Class II | Ongoing | 8 Apr 2026 |
| Z-1765-2026 | Burlington Medical, Kilt Blockers. | 94 units | Class II | Ongoing | 8 Apr 2026 |
openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports.
Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.
Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.
Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.
Class II: The middle of the three FDA recall classes.
The event in context
- Device events that started in 2026
- 572
- Share of these events in Class II
- 87%
- Product records in this event
- 13Median of the firm: 24
- Events of the firm on the register
- 2
Other events of the firm
| Initiated | Product (first record) | Type | Class | Records |
|---|---|---|---|---|
| 7 Jun 2019 | Frontal Stretch Buckle Closure Apron, Product Number A-10, Part Numbers REA10A, REA10B, REA10C, REA10*F, REA10*M, UEA10* | Device | Class II | 24 |
Official channels
- FDA enforcement report Z-1753-2026The FDA record of the first product of this event.
- FDA: recalls, market withdrawals and safety alertsThe recall notices on the FDA site.
- FDA MedWatchThe FDA safety reporting program for drugs and medical devices.
Follow by RSS:Food, drug and device recallsFDA Class I recalls
Cite this page
Recall Register. FDA enforcement event 98415. https://recallregister.com/fda/ii/98415/. Source: openFDA enforcement reports. Data through .
Sources
- Source
- openFDA device enforcement reports
- Licence
- CC0 1.0
- Export date
- 28 Sep 2026
- Newest FDA report date on the register
- 23 Sep 2026
FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.
Questions
- Where was the product distributed?
- The FDA record gives this distribution:
Worldwide distribution. Nationwide distribution in the US and international distribution to Canada, Australia, Bangladesh, Chile, Hong Kong, India, Mexico, Malaysia, Panama, Singapore, Thailand,…
- What quantity of product is in FDA event 98415?
- The event has 13 product records. The first record gives this quantity:
41,962 units
- How did the recall start?
- The FDA record says:
Voluntary: Firm initiated
- How many device recalls of 2026 have the same class?
- 87% of the 572 device events that started in 2026 are in Class II.